Literature DB >> 24616423

Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects.

Elizabeth V Nguyen1, Sina A Gharib, Lynn M Schnapp, David R Goodlett.   

Abstract

We provide a review of proteomic techniques used to characterize the bronchoalveolar lavage fluid (BALF) proteome of normal healthy subjects. Bronchoalveolar lavage (BAL) is the most common technique for sampling the components of the alveolar space. The proteomic techniques used to study normal BALF include protein separation by 2DE, whereby proteins were identified by comparison to a reference gel as well as high pressure liquid chromatography (HPLC)-MS/MS, also known as shotgun proteomics. We summarize recent progress using shotgun MS technologies to define the normal BALF proteome. Surprisingly, we find that despite advances in shotgun proteomic technologies over the course of the last 10 years, which have resulted in greater numbers of proteins being identified, the functional landscape of normal BALF proteome was similarly described by all methods examined.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Bronchoalveolar lavage fluid; Epithelial lining fluid; MS

Mesh:

Year:  2014        PMID: 24616423      PMCID: PMC4239657          DOI: 10.1002/prca.201300018

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  70 in total

1.  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest.

Authors:  C S Spahr; M T Davis; M D McGinley; J H Robinson; E J Bures; J Beierle; J Mort; P L Courchesne; K Chen; R C Wahl; W Yu; R Luethy; S D Patterson
Journal:  Proteomics       Date:  2001-01       Impact factor: 3.984

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

3.  Protein pattern of exhaled breath condensate and saliva.

Authors:  Matthias Griese; Jochen Noss; Christina von Bredow
Journal:  Proteomics       Date:  2002-06       Impact factor: 3.984

Review 4.  Top-down proteomics.

Authors:  Neil L Kelleher
Journal:  Anal Chem       Date:  2004-06-01       Impact factor: 6.986

5.  Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides.

Authors:  Alexander Scherl; Scott A Shaffer; Gregory K Taylor; Hemantha D Kulasekara; Samuel I Miller; David R Goodlett
Journal:  Anal Chem       Date:  2008-01-23       Impact factor: 6.986

6.  Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury.

Authors:  Lynn M Schnapp; Samuel Donohoe; Jinzhi Chen; Donald A Sunde; Patricia M Kelly; John Ruzinski; Thomas Martin; David R Goodlett
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 7.  Lung epithelium-specific proteins: characteristics and potential applications as markers.

Authors:  C Hermans; A Bernard
Journal:  Am J Respir Crit Care Med       Date:  1999-02       Impact factor: 21.405

8.  Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Authors:  J M Diamond; S M Kawut; D J Lederer; V N Ahya; B Kohl; J Sonett; S M Palmer; M Crespo; K Wille; V N Lama; P D Shah; J Orens; S Bhorade; A Weinacker; E Demissie; S Bellamy; J D Christie; L B Ware
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

Review 9.  Is bronchoalveolar lavage obsolete in the diagnosis of interstitial lung disease?

Authors:  Paola Rottoli; Elena Bargagli
Journal:  Curr Opin Pulm Med       Date:  2003-09       Impact factor: 3.155

10.  Of mice and men: comparative proteomics of bronchoalveolar fluid.

Authors:  S A Gharib; E Nguyen; W A Altemeier; S A Shaffer; C E Doneanu; D R Goodlett; L M Schnapp
Journal:  Eur Respir J       Date:  2009-12-23       Impact factor: 16.671

View more
  7 in total

Review 1.  Mass Spectrometry-based Proteomics in Acute Respiratory Distress Syndrome: A Powerful Modality for Pulmonary Precision Medicine.

Authors:  Xue-Feng Xu; Hua-Ping Dai; Yan-Ming Li; Fei Xiao; Chen Wang
Journal:  Chin Med J (Engl)       Date:  2016-10-05       Impact factor: 2.628

2.  Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.

Authors:  Abduladim Hmmier; Michael Emmet O'Brien; Vincent Lynch; Martin Clynes; Ross Morgan; Paul Dowling
Journal:  BBA Clin       Date:  2017-03-06

Review 3.  Phosphoproteome Discovery in Human Biological Fluids.

Authors:  Francesco Giorgianni; Sarka Beranova-Giorgianni
Journal:  Proteomes       Date:  2016-12-01

4.  The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.

Authors:  Olivier Touzelet; Lindsay Broadbent; Stuart D Armstrong; Waleed Aljabr; Elaine Cloutman-Green; Ultan F Power; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2020-02-19       Impact factor: 5.911

5.  diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls.

Authors:  María Del Sol Arenas-De Larriva; Alejandro Fernández-Vega; Bernabe Jurado-Gamez; Ignacio Ortea
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

6.  Application of clinical proteomics in acute respiratory distress syndrome.

Authors:  Maneesh Bhargava; LeeAnn Higgins; Christine H Wendt; David H Ingbar
Journal:  Clin Transl Med       Date:  2014-10-15

Review 7.  The proteomics of lung injury in childhood: challenges and opportunities.

Authors:  Prue M Pereira-Fantini; David G Tingay
Journal:  Clin Proteomics       Date:  2016-02-29       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.